Physician profile
Jonathan Pham
NPI 1699236299
$4,798.27
in general payments reported to CMS, 2019-2025
14 companies · $536 in 2025
The $536 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,176 · 2024: $2,087 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,593 · Education: $1,135 · Travel and Lodging: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,593.21 |
| Education | $1,134.80 |
| Travel and Lodging | $1,070.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,994.25 | 2023-2024 | Senza |
| Boston Scientific Corporation | $763.84 | 2024 | |
| Medtronic, INC. | $621.88 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Collegium Pharmaceutical, INC. | $237.00 | 2024-2025 | Belbuca, Xtampza |
| Spinal Simplicity, LLC | $230.46 | 2024 | Ha Minuteman G3-R |
| Stryker Corporation | $214.94 | 2024-2025 | Spinejack, Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.02 | 2024-2025 | Relistor |
| Painteq LLC | $166.10 | 2023 | Painteq |
| Abbott Laboratories | $154.82 | 2024 | Eterna |
| Nalu Medical, INC. | $129.55 | 2024 | Nalu Neurostimulation System |
| Virtus Pharmaceuticals LLC | $41.98 | 2025 | Levorphanol Tartrate |
| Lundbeck LLC | $29.45 | 2024 | Vyepti |
| Scilex Pharmaceuticals INC. | $21.41 | 2025 | |
| Microtransponder, INC. | $14.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.